SOMATIC CELL GENETIC ANALYSIS OF PURINE SYNTHESIS

嘌呤合成的体细胞遗传学分析

基本信息

  • 批准号:
    6138657
  • 负责人:
  • 金额:
    $ 23.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-01-01 至 2001-12-31
  • 项目状态:
    已结题

项目摘要

Purines are fundamental biological molecules. They are components of DNA and RNA, the genetic information of all living organisms. Purines are critical as intracellular signaling molecules in the form of cAMP and cGMP, and are important intercellular signaling molecules functioning as neurotransmitters and as signaling molecules important for vasodilation and other physiological processes. ATP serves as a key molecule in energy metabolism. Many coenzymes are purine based. Genetic and biochemical regulation of purine synthesis in mammals and humans must be complex, involving several enzymatic steps and proteins. The pathway is almost certainly developmentally regulated in mammals and humans as well. These conclusions are based almost entirely on studies of the biochemistry of the pathway in whole cells or in cell free extracts. That such regulation must exist seems obvious. However, the molecular mechanisms of regulation remain to be defined. In no case has a detailed molecular analysis of the regulation of purine synthesis in an animal or in animal cells in culture been carried out. This is largely because until now the molecular reagents necessary have not existed. Without this information, it will be difficult to understand the role of the pathway in human disease and to intervene appropriately. The first seven steps of the pathway and genes encoding these are critically involved in the environmental, developmental, and genetic regulation of the pathway, and propose to use a novel set of reagents and capabilities, including human and Chinese hamster cDNA and genomic clones, antibodies recognizing functional domains of the proteins carrying out the fist seven steps and which are suitable for Western blotting, immuneprecipitation, and immunocytochemistry, and Chinese hamster ovary (CHO) cell mutants to understand these regulatory mechanisms. The roles of multi-enzyme complexes, multi functional proteins, transcriptional, translational, and posttranslational regulation of these five enzymatic steps in the regulation of purine synthesis will be evaluated. The following specific aims are proposed: (1) Determination of the nature and effects of mutations in CHO cells in the first seven steps of the pathway on the regulation of purine synthesis and purine levels; (2) Determination of transcriptional translational, and posttranslational regulation of these enzymes in response to alterations in environmental conditions using CHO cell cultures; (3) Determination of transcriptional, translational or posttranslational regulation of the first seven steps of the pathway during human and mouse development, (4) Assessment of the existence of multi-enzyme complexes involving the first seven steps of the de novo pathway and assessment of whether these complexes have regulatory significance.
嘌呤是基本的生物分子。它们是 DNA和RNA,所有生物的遗传信息。[医]嘌呤 作为cAMP形式的细胞内信号分子是至关重要的 和cGMP,是重要的细胞间信号分子 作为神经递质和重要的信号分子发挥作用 用于血管扩张和其他生理过程。ATP是一把钥匙 能量代谢中的分子。许多辅酶是以嘌呤为基础的。 哺乳动物和哺乳动物体内嘌呤合成的遗传和生化调控 人类肯定是复杂的,涉及几个酶步骤和蛋白质。 几乎可以肯定,该途径在哺乳动物中是发育调节的,并且 人类也是如此。这些结论几乎完全基于研究。 整个细胞或游离细胞中该途径的生物化学 萃取物。这样的监管必须存在似乎是显而易见的。然而, 调控的分子机制尚不清楚。在任何情况下都没有 植物体内嘌呤合成调控的详细分子分析 一种动物或在动物细胞中进行培养。这是 很大程度上是因为到目前为止,所需的分子试剂还没有 曾经存在过。如果没有这些信息,就很难理解 该途径在人类疾病中的作用并进行适当的干预。 该途径的前七个步骤和编码这些步骤的基因是 与环境、发育和遗传密切相关 调节该途径,并建议使用一组新的试剂 和能力,包括人和中国仓鼠的基因和基因组 识别蛋白质功能结构域的克隆、抗体 实施前七个步骤,适合西方人 免疫印迹、免疫沉淀和免疫细胞化学 仓鼠卵巢(CHO)细胞突变体了解这些调控 机制。 多酶复合体、多功能蛋白质、 转录、翻译和翻译后调控 调节嘌呤合成的这五个酶步骤将 被评估。提出了以下具体目标:(1) 中国仓鼠卵巢细胞突变的性质和影响的测定 嘌呤合成调控途径的前七步 和嘌呤水平;(2)转录翻译水平的测定, 以及对这些酶的翻译后调节以响应 利用CHO细胞培养改变环境条件;(3) 转录、翻译或翻译后的判定 在人类和人类发育过程中对该通路前七步的调节 小鼠发育,(4)多酶存在的评估 涉及从头开始途径的前七个步骤的复合体 评估这些复合体是否具有调节意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID PATTERSON其他文献

DAVID PATTERSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID PATTERSON', 18)}}的其他基金

Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    7248057
  • 财政年份:
    2004
  • 资助金额:
    $ 23.56万
  • 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    6926190
  • 财政年份:
    2004
  • 资助金额:
    $ 23.56万
  • 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    7082872
  • 财政年份:
    2004
  • 资助金额:
    $ 23.56万
  • 项目类别:
Proteomics for Testing Hypotheses about Down Syndrome
用于检验唐氏综合症假设的蛋白质组学
  • 批准号:
    6826136
  • 财政年份:
    2004
  • 资助金额:
    $ 23.56万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    6868232
  • 财政年份:
    2003
  • 资助金额:
    $ 23.56万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    6579811
  • 财政年份:
    2003
  • 资助金额:
    $ 23.56万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    6703721
  • 财政年份:
    2003
  • 资助金额:
    $ 23.56万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    7172954
  • 财政年份:
    2003
  • 资助金额:
    $ 23.56万
  • 项目类别:
AUTISM AND AMPS LYASE MUTATIONS: CELL AND MOUSE MODELS
自闭症和 AMPS 裂解酶突变:细胞和小鼠模型
  • 批准号:
    7012827
  • 财政年份:
    2003
  • 资助金额:
    $ 23.56万
  • 项目类别:
PURINE, FOLATE, AND REACTIVE OXYGEN METABOLISM AND DOWN SYNDROME
嘌呤、叶酸和活性氧代谢与唐氏综合症
  • 批准号:
    6301897
  • 财政年份:
    2000
  • 资助金额:
    $ 23.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了